Updates have been made to the U.S. Government Patient Assistance Program (USG PAP) for Paxlovid to ensure continued access to this COVID-19 treatment.
Currently, Medicare patients may access Paxlovid via a 100 percent rebate program or directly
enrolling in the USG PAP. Starting on March 1, 2025, Medicare patients who are under-insured and those who do not have prescription coverage and cannot afford the treatment may be eligible to access Paxlovid at no cost.
Patients who are covered under Medicaid, Tricare, or Veterans Affairs Community Care Network should check with their plans for coverage information. If they have high co-pays and are not able to afford Paxlovid, they too may be eligible to enroll for the USG PAP.
The
USG PAP continues to be an avenue through with eligible individuals can access Paxlovid at no cost.